McDonald’s is finally selling the Chicken Big Mac in the US
When McDonald’s rolled out the Chicken Big Mac in the United Kingdom, it sold out within ten days. Now, it’s likely hoping for a similar success story in the United States.
Related Articles
What to expect from big retailers providing healthcare in 2025
Walgreens and Walmart have stepped back from their healthcare services ventures, but CVS, Kroger and Amazon are forging ahead.
Fibrolamellar hepatocellular carcinoma and biopsy-proven right hilar mass and lung nodules
A 36-year-old man with a 6-month history of asthenia, impotence, loss of libido, polyuria, and polydipsia attended our department; he also reported needing to wake…
Multidisciplinary Approaches to Paraneoplastic LEMS: Insights for Healthcare Decision-Makers
A medical expert discusses the key aspects of Lambert-Eaton Myasthenic Syndrome (LEMS) in the context of small cell lung cancer (SCLC), including its differential diagnosis,…
FDA: Veozah, First Hormone-Free Hot Flash Drug, Issued Black Box Warning
WEDNESDAY, Dec. 18, 2024 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has issued its most serious warning — a black-box warning —…
I asked ChatGPT, Claude AI, Gemini, and Siri about humanoid robots in 2025, and the responses shocked me
Where are my robot friends?
USPSTF Recommends Against Vitamin D Supplementation for Fracture, Fall Prevention
TUESDAY, Dec. 17, 2024 (HealthDay News) — The U.S. Preventive Services Task Force (USPSTF) recommends against vitamin D supplementation, with or without calciu
Florida unveils new artificial intelligence-driven emergency messaging system
The BEACON system converts important safety information from text to voice and delivers it over the radio within minutes of being issued.
Colon Cancer Rates Are Up Among the Young Worldwide
MONDAY, Dec. 16, 2024 (HealthDay News) — More young people around the world are falling prey to colon cancer, a new study shows.Colon cancer rates…
New CMS model could slash provider earnings: researchers
An Institute for Accountable Care report says hospitals could lose an average of $500 per episode of covered services — but the forecast varies widely.
Eli Lilly’s obesity drug Zepbound approved to treat sleep apnea in U.S.
The FDA has cleared Eli Lilly’s obesity drug Zepbound as the first treatment for obstructive sleep apnea in the U.S.
